Generic Name and Formulations:
Moxifloxacin (as HCl) 0.5%; oph soln.
Alcon Laboratories, Inc.
Indications for VIGAMOX:
Susceptible bacterial conjunctivitis.
Adults and Children:
Instill 1 drop 3 times daily for 7 days.
For topical ophthalmic use only. Discontinue if superinfection or hypersensitivity occurs. Avoid contact lenses if symptomatic. Pregnancy (Cat.C). Nursing mothers.
Conjunctivitis, decreased visual acuity, dry eye, keratitis, ocular discomfort, hyperemia, pain, pruritus, subconjunctival hemorrhage, tearing.
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Serious Adverse Events Profile for Cladribine Confirmed With Extended Data
- Unintended Pregnancy Common in Women With Epilepsy
- Aggressive Blood Pressure Lowering in Intracerebral Hemorrhage May Be Harmful
- Risk of Opioid-Benzodiazepine Overlap Up for Dual Prescribing
- Minority Residents Experience Burdens Linked to Race/Ethnicity
- Tips Provided for Budgeting in Medical Residency